Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where James E. Galagan is active.

Publication


Featured researches published by James E. Galagan.


Nature | 2005

Sequencing of Aspergillus nidulans and comparative analysis with A. fumigatus and A. oryzae

James E. Galagan; Sarah E. Calvo; Christina A. Cuomo; Li-Jun Ma; Jennifer R. Wortman; Serafim Batzoglou; Su-In Lee; Meray Baştürkmen; Christina C. Spevak; John Clutterbuck; Vladimir V. Kapitonov; Jerzy Jurka; Claudio Scazzocchio; Mark L. Farman; Jonathan Butler; Seth Purcell; Steve Harris; Gerhard H. Braus; Oliver W. Draht; Silke Busch; Christophe d'Enfert; Christiane Bouchier; Gustavo H. Goldman; Deborah Bell-Pedersen; Sam Griffiths-Jones; John H. Doonan; Jae-Hyuk Yu; Kay Vienken; Arnab Pain; Michael Freitag

The aspergilli comprise a diverse group of filamentous fungi spanning over 200 million years of evolution. Here we report the genome sequence of the model organism Aspergillus nidulans, and a comparative study with Aspergillus fumigatus, a serious human pathogen, and Aspergillus oryzae, used in the production of sake, miso and soy sauce. Our analysis of genome structure provided a quantitative evaluation of forces driving long-term eukaryotic genome evolution. It also led to an experimentally validated model of mating-type locus evolution, suggesting the potential for sexual reproduction in A. fumigatus and A. oryzae. Our analysis of sequence conservation revealed over 5,000 non-coding regions actively conserved across all three species. Within these regions, we identified potential functional elements including a previously uncharacterized TPP riboswitch and motifs suggesting regulation in filamentous fungi by Puf family genes. We further obtained comparative and experimental evidence indicating widespread translational regulation by upstream open reading frames. These results enhance our understanding of these widely studied fungi as well as provide new insight into eukaryotic genome evolution and gene regulation.


Nature | 2005

The genome sequence of the rice blast fungus Magnaporthe grisea

Ralph A. Dean; Nicholas J. Talbot; Daniel J. Ebbole; Mark L. Farman; Thomas K. Mitchell; Marc J. Orbach; Michael R. Thon; Resham Kulkarni; Jin-Rong Xu; Huaqin Pan; Nick D. Read; Yong-Hwan Lee; Ignazio Carbone; Doug Brown; Yeon Yee Oh; Nicole M. Donofrio; Jun Seop Jeong; Darren M. Soanes; Slavica Djonović; Elena Kolomiets; Cathryn J. Rehmeyer; Weixi Li; Michael Harding; Soonok Kim; Marc-Henri Lebrun; Heidi U. Böhnert; Sean Coughlan; Jonathan Butler; Sarah E. Calvo; Li-Jun Ma

Magnaporthe grisea is the most destructive pathogen of rice worldwide and the principal model organism for elucidating the molecular basis of fungal disease of plants. Here, we report the draft sequence of the M. grisea genome. Analysis of the gene set provides an insight into the adaptations required by a fungus to cause disease. The genome encodes a large and diverse set of secreted proteins, including those defined by unusual carbohydrate-binding domains. This fungus also possesses an expanded family of G-protein-coupled receptors, several new virulence-associated genes and large suites of enzymes involved in secondary metabolism. Consistent with a role in fungal pathogenesis, the expression of several of these genes is upregulated during the early stages of infection-related development. The M. grisea genome has been subject to invasion and proliferation of active transposable elements, reflecting the clonal nature of this fungus imposed by widespread rice cultivation.


Nature | 2005

Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus.

William C. Nierman; Arnab Pain; Michael J. Anderson; Jennifer R. Wortman; H. Stanley Kim; Javier Arroyo; Matthew Berriman; Keietsu Abe; David B. Archer; Clara Bermejo; Joan W. Bennett; Paul Bowyer; Dan Chen; Matthew Collins; Richard Coulsen; Robert Davies; Paul S. Dyer; Mark L. Farman; Nadia Fedorova; Natalie D. Fedorova; Tamara V. Feldblyum; Reinhard Fischer; Nigel Fosker; Audrey Fraser; José Luis García; María José García; Ariette Goble; Gustavo H. Goldman; Katsuya Gomi; Sam Griffith-Jones

Aspergillus fumigatus is exceptional among microorganisms in being both a primary and opportunistic pathogen as well as a major allergen. Its conidia production is prolific, and so human respiratory tract exposure is almost constant. A. fumigatus is isolated from human habitats and vegetable compost heaps. In immunocompromised individuals, the incidence of invasive infection can be as high as 50% and the mortality rate is often about 50% (ref. 2). The interaction of A. fumigatus and other airborne fungi with the immune system is increasingly linked to severe asthma and sinusitis. Although the burden of invasive disease caused by A. fumigatus is substantial, the basic biology of the organism is mostly obscure. Here we show the complete 29.4-megabase genome sequence of the clinical isolate Af293, which consists of eight chromosomes containing 9,926 predicted genes. Microarray analysis revealed temperature-dependent expression of distinct sets of genes, as well as 700 A. fumigatus genes not present or significantly diverged in the closely related sexual species Neosartorya fischeri, many of which may have roles in the pathogenicity phenotype. The Af293 genome sequence provides an unparalleled resource for the future understanding of this remarkable fungus.


Nature | 2005

Genome sequencing and analysis of Aspergillus oryzae

Masayuki Machida; Kiyoshi Asai; Motoaki Sano; Toshihiro Tanaka; Toshitaka Kumagai; Goro Terai; Ken Ichi Kusumoto; Toshihide Arima; Osamu Akita; Yutaka Kashiwagi; Keietsu Abe; Katsuya Gomi; Hiroyuki Horiuchi; Katsuhiko Kitamoto; Tetsuo Kobayashi; Michio Takeuchi; David W. Denning; James E. Galagan; William C. Nierman; Jiujiang Yu; David B. Archer; Joan W. Bennett; Deepak Bhatnagar; Thomas E. Cleveland; Natalie D. Fedorova; Osamu Gotoh; Hiroshi Horikawa; Akira Hosoyama; Masayuki Ichinomiya; Rie Igarashi

The genome of Aspergillus oryzae, a fungus important for the production of traditional fermented foods and beverages in Japan, has been sequenced. The ability to secrete large amounts of proteins and the development of a transformation system have facilitated the use of A. oryzae in modern biotechnology. Although both A. oryzae and Aspergillus flavus belong to the section Flavi of the subgenus Circumdati of Aspergillus, A. oryzae, unlike A. flavus, does not produce aflatoxin, and its long history of use in the food industry has proved its safety. Here we show that the 37-megabase (Mb) genome of A. oryzae contains 12,074 genes and is expanded by 7–9u2009Mb in comparison with the genomes of Aspergillus nidulans and Aspergillus fumigatus. Comparison of the three aspergilli species revealed the presence of syntenic blocks and A. oryzae-specific blocks (lacking synteny with A. nidulans and A. fumigatus) in a mosaic manner throughout the genome of A. oryzae. The blocks of A. oryzae-specific sequence are enriched for genes involved in metabolism, particularly those for the synthesis of secondary metabolites. Specific expansion of genes for secretory hydrolytic enzymes, amino acid metabolism and amino acid/sugar uptake transporters supports the idea that A. oryzae is an ideal microorganism for fermentation.


Science | 2007

Genome sequence of Aedes aegypti, a major arbovirus vector

Vishvanath Nene; Jennifer R. Wortman; Daniel John Lawson; Brian J. Haas; Chinnappa D. Kodira; Zhijian Jake Tu; Brendan J. Loftus; Zhiyong Xi; Karyn Megy; Manfred Grabherr; Quinghu Ren; Evgeny M. Zdobnov; Neil F. Lobo; Kathryn S. Campbell; Susan E. Brown; Maria F. Bonaldo; Jingsong Zhu; Steven P. Sinkins; David G. Hogenkamp; Paolo Amedeo; Peter Arensburger; Peter W. Atkinson; Shelby Bidwell; Jim Biedler; Ewan Birney; Robert V. Bruggner; Javier Costas; Monique R. Coy; Jonathan Crabtree; Matt Crawford

We present a draft sequence of the genome of Aedes aegypti, the primary vector for yellow fever and dengue fever, which at ∼1376 million base pairs is about 5 times the size of the genome of the malaria vector Anopheles gambiae. Nearly 50% of the Ae. aegypti genome consists of transposable elements. These contribute to a factor of ∼4 to 6 increase in average gene length and in sizes of intergenic regions relative to An. gambiae and Drosophila melanogaster. Nonetheless, chromosomal synteny is generally maintained among all three insects, although conservation of orthologous gene order is higher (by a factor of ∼2) between the mosquito species than between either of them and the fruit fly. An increase in genes encoding odorant binding, cytochrome P450, and cuticle domains relative to An. gambiae suggests that members of these protein families underpin some of the biological differences between the two mosquito species.


Nature | 2010

Comparative genomics reveals mobile pathogenicity chromosomes in Fusarium

Li-Jun Ma; H. Charlotte van der Does; Katherine A. Borkovich; Jeffrey J. Coleman; Marie Josée Daboussi; Antonio Di Pietro; Marie Dufresne; Michael Freitag; Manfred Grabherr; Bernard Henrissat; Petra M. Houterman; Seogchan Kang; Won Bo Shim; Charles P. Woloshuk; Xiaohui Xie; Jin-Rong Xu; John Antoniw; Scott E. Baker; Burton H. Bluhm; Andrew Breakspear; Daren W. Brown; Robert A. E. Butchko; Sinéad B. Chapman; Richard M. R. Coulson; Pedro M. Coutinho; Etienne Danchin; Andrew C. Diener; Liane R. Gale; Donald M. Gardiner; Stephen A. Goff

Fusarium species are among the most important phytopathogenic and toxigenic fungi. To understand the molecular underpinnings of pathogenicity in the genus Fusarium, we compared the genomes of three phenotypically diverse species: Fusarium graminearum, Fusarium verticillioides and Fusarium oxysporum f. sp. lycopersici. Our analysis revealed lineage-specific (LS) genomic regions in F. oxysporum that include four entire chromosomes and account for more than one-quarter of the genome. LS regions are rich in transposons and genes with distinct evolutionary profiles but related to pathogenicity, indicative of horizontal acquisition. Experimentally, we demonstrate the transfer of two LS chromosomes between strains of F. oxysporum, converting a non-pathogenic strain into a pathogen. Transfer of LS chromosomes between otherwise genetically isolated strains explains the polyphyletic origin of host specificity and the emergence of new pathogenic lineages in F. oxysporum. These findings put the evolution of fungal pathogenicity into a new perspective.


Nature | 2006

Insights from the genome of the biotrophic fungal plant pathogen Ustilago maydis

Jörg Kämper; Regine Kahmann; Michael Bölker; Li-Jun Ma; Thomas Brefort; Barry J. Saville; Flora Banuett; James W. Kronstad; Scott E. Gold; Olaf Müller; Michael H. Perlin; Han A. B. Wösten; Ronald P. de Vries; José Ruiz-Herrera; Cristina G. Reynaga-Peña; Karen M. Snetselaar; Michael McCann; José Pérez-Martín; Michael Feldbrügge; Christoph W. Basse; Gero Steinberg; Jose I. Ibeas; William Holloman; Plinio Guzman; Mark L. Farman; Jason E. Stajich; Rafael Sentandreu; Juan M. González-Prieto; John C. Kennell; Lázaro Molina

Ustilago maydis is a ubiquitous pathogen of maize and a well-established model organism for the study of plant–microbe interactions. This basidiomycete fungus does not use aggressive virulence strategies to kill its host. U. maydis belongs to the group of biotrophic parasites (the smuts) that depend on living tissue for proliferation and development. Here we report the genome sequence for a member of this economically important group of biotrophic fungi. The 20.5-million-base U. maydis genome assembly contains 6,902 predicted protein-encoding genes and lacks pathogenicity signatures found in the genomes of aggressive pathogenic fungi, for example a battery of cell-wall-degrading enzymes. However, we detected unexpected genomic features responsible for the pathogenicity of this organism. Specifically, we found 12 clusters of genes encoding small secreted proteins with unknown function. A significant fraction of these genes exists in small gene families. Expression analysis showed that most of the genes contained in these clusters are regulated together and induced in infected tissue. Deletion of individual clusters altered the virulence of U. maydis in five cases, ranging from a complete lack of symptoms to hypervirulence. Despite years of research into the mechanism of pathogenicity in U. maydis, no ‘true’ virulence factors had been previously identified. Thus, the discovery of the secreted protein gene clusters and the functional demonstration of their decisive role in the infection process illuminate previously unknown mechanisms of pathogenicity operating in biotrophic fungi. Genomic analysis is, similarly, likely to open up new avenues for the discovery of virulence determinants in other pathogens.


Nature Genetics | 2010

Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved

Iñaki Comas; Jaidip Chakravartti; Peter M. Small; James E. Galagan; Stefan Niemann; Kristin Kremer; Joel D. Ernst; Sebastien Gagneux

Mycobacterium tuberculosis is an obligate human pathogen capable of persisting in individual hosts for decades. We sequenced the genomes of 21 strains representative of the global diversity and six major lineages of the M. tuberculosis complex (MTBC) at 40- to 90-fold coverage using Illumina next-generation DNA sequencing. We constructed a genome-wide phylogeny based on these genome sequences. Comparative analyses of the sequences showed, as expected, that essential genes in MTBC were more evolutionarily conserved than nonessential genes. Notably, however, most of the 491 experimentally confirmed human T cell epitopes showed little sequence variation and had a lower ratio of nonsynonymous to synonymous changes than seen in essential and nonessential genes. We confirmed these findings in an additional data set consisting of 16 antigens in 99 MTBC strains. These findings are consistent with strong purifying selection acting on these epitopes, implying that MTBC might benefit from recognition by human T cells.


Hepatology | 2008

Naturally Occurring Dominant Resistance Mutations to Hepatitis C Virus Protease and Polymerase Inhibitors in Treatment-Naïve Patients

Thomas Kuntzen; Joerg Timm; Andrew Berical; Niall J. Lennon; Aaron M. Berlin; Sarah K. Young; Bongshin Lee; David Heckerman; Jonathan M. Carlson; Laura L. Reyor; Marianna Kleyman; Cory McMahon; Christopher Birch; Julian Schulze zur Wiesch; Timothy Ledlie; Michael Koehrsen; Chinnappa D. Kodira; Andrew Roberts; Georg M. Lauer; Hugo R. Rosen; Florian Bihl; Andreas Cerny; Ulrich Spengler; Zhimin Liu; Arthur Y. Kim; Yanming Xing; Arne Schneidewind; Margaret A. Madey; Jaquelyn F. Fleckenstein; Vicki Park

Resistance mutations to hepatitis C virus (HCV) nonstructural protein 3 (NS3) protease inhibitors in <1% of the viral quasispecies may still allow >1000‐fold viral load reductions upon treatment, consistent with their reported reduced replicative fitness in vitro. Recently, however, an R155K protease mutation was reported as the dominant quasispecies in a treatment‐naïve individual, raising concerns about possible full drug resistance. To investigate the prevalence of dominant resistance mutations against specifically targeted antiviral therapy for HCV (STAT‐C) in the population, we analyzed HCV genome sequences from 507 treatment‐naïve patients infected with HCV genotype 1 from the United States, Germany, and Switzerland. Phylogenetic sequence analysis and viral load data were used to identify the possible spread of replication‐competent, drug‐resistant viral strains in the population and to infer the consequences of these mutations upon viral replication in vivo. Mutations described to confer resistance to the protease inhibitors Telaprevir, BILN2061, ITMN‐191, SCH6 and Boceprevir; the NS5B polymerase inhibitor AG‐021541; and to the NS4A antagonist ACH‐806 were observed mostly as sporadic, unrelated cases, at frequencies between 0.3% and 2.8% in the population, including two patients with possible multidrug resistance. Collectively, however, 8.6% of the patients infected with genotype 1a and 1.4% of those infected with genotype 1b carried at least one dominant resistance mutation. Viral loads were high in the majority of these patients, suggesting that drug‐resistant viral strains might achieve replication levels comparable to nonresistant viruses in vivo. Conclusion: Naturally occurring dominant STAT‐C resistance mutations are common in treatment‐naïve patients infected with HCV genotype 1. Their influence on treatment outcome should further be characterized to evaluate possible benefits of drug resistance testing for individual tailoring of drug combinations when treatment options are limited due to previous nonresponse to peginterferon and ribavirin. (HEPATOLOGY 2008;48:1769–1778.)


Nature Genetics | 2012

Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes

Iñaki Comas; Sonia Borrell; Andreas Roetzer; Graham Rose; Bijaya Malla; Midori Kato-Maeda; James E. Galagan; Stefan Niemann; Sebastien Gagneux

Epidemics of drug-resistant bacteria emerge worldwide, even as resistant strains frequently have reduced fitness compared to their drug-susceptible counterparts. Data from model systems suggest that the fitness cost of antimicrobial resistance can be reduced by compensatory mutations; however, there is limited evidence that compensatory evolution has any significant role in the success of drug-resistant bacteria in human populations. Here we describe a set of compensatory mutations in the RNA polymerase genes of rifampicin-resistant M. tuberculosis, the etiologic agent of human tuberculosis (TB). M. tuberculosis strains harboring these compensatory mutations showed a high competitive fitness in vitro. Moreover, these mutations were associated with high fitness in vivo, as determined by examining their relative clinical frequency across patient populations. Of note, in countries with the worlds highest incidence of multidrug-resistant (MDR) TB, more than 30% of MDR clinical isolates had this form of mutation. Our findings support a role for compensatory evolution in the global epidemics of MDR TB.

Collaboration


Dive into the James E. Galagan's collaboration.

Top Co-Authors

Avatar

Li-Jun Ma

University of Massachusetts Amherst

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge